Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches

« PreviousJournal of Molecular and Cellular Cardiology
Volume 47, Issue 6 , Pages 835-845, December 2009

Ning Li
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Jun-Yan Liu
- Department of Entomology and UCD Cancer Center, University of California, Davis, CA, USA
Valeriy Timofeyev
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Hong Qiu
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Sung Hee Hwang
- Department of Entomology and UCD Cancer Center, University of California, Davis, CA, USA
Dipika Tuteja
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Ling Lu
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Jun Yang
- Department of Entomology and UCD Cancer Center, University of California, Davis, CA, USA
Hideki Mochida
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Reginald Low
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
Bruce D. Hammock
- Department of Entomology and UCD Cancer Center, University of California, Davis, CA, USA
Nipavan Chiamvimonvat
- Division of Cardiovascular Medicine, University of California, Davis, Davis, CA, USA
- Department of Veterans Affairs, Northern California Health Care System, Mather, CA, USA
- Corresponding author. Division of Cardiovascular Medicine, University of California, Davis, One Shields Avenue, GBSF 6315, Davis, CA 95616, USA. Fax: +1 530 752 3264.